Monitoring minimal residual disease in the bone marrow using next generation sequencing← ALL PUBLICATIONSMonitoring minimal residual disease in the bone marrow using next generation sequencingJanuary 17th, 2020VIEW PUBLICATION ⟶AUTHORS Even H. Rustad, MD, PhD / Eileen M. Boyle, MD, MSc marketing2021-02-11T22:00:56+00:00
